CING - Cingulate Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.54 -0.54 (-11.89%) --- 0.0 (0.07%) 0.02 (0.5%) -0.35 (-7.71%) -0.17 (-4.2%) -0.01 (-0.25%) -0.01 (-0.25%)

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.09
Diluted EPS:
-1.09
Basic P/E:
-3.6697
Diluted P/E:
-3.6697
RSI(14) 1m:
50.0
VWAP:
4.0
RVol:
2.9537

Events

Period Kind Movement Occurred At
10m Price decrease 10m 4.11 -0.18 (-4.23%) Oct 15 08:57
1m Price decrease 1m 4.11 -0.12 (-2.84%) Oct 15 08:57
1m Price decrease 1m 4.22 -0.05 (-1.17%) Oct 15 06:53
60m Price decrease 60m 4.27 -0.26 (-5.74%) Oct 15 05:23
1m Price increase 1m 4.53 +0.08 (+1.8%) Oct 15 05:02

Related News